February 18, 2019
Oncopeptides will host a webcast in conjunction with its Year-end Report 2018 on 22 February at 14.00 (CET)
Media
February 15, 2019
Rainier Therapeutics Presents Data on Vofatamab in Patients with Advanced Urothelial Cell Carcinoma (Bladder Cancer) Previously Treated with Chemotherapy at ASCO GU 2019
February 14, 2019
Targovax ASA: Fourth quarter and full year 2018 results
February 14, 2019
MIPS – Year end report 2018
February 13, 2019
Vicore Pharma postpones publication of year-end report
February 13, 2019
Correction of error Q3 (18) report
February 12, 2019
Intravitreal administration of GS010 in patients with LHON was safe and well tolerated
February 11, 2019
First patient treated in dose expansion cohort of Targovax’s ONCOS-102 trial in melanoma
February 08, 2019
BONESUPPORT – Publication of pre-clinical study highlighting unique bone remodeling qualities of CERAMENT® in large bone defects
February 04, 2019
GenSight Biologics reports topline results at Week 48 of the RESCUE Phase III clinical trial of GS010 in subjects within six months of visual loss onset due to Leber Hereditary Optic Neuropathy (LHON)
